Global Diagnostics and Disease Area Strategist, Alzheimer’s

Biogen·
Cambridge, MA
5d ago
Full-timeNeurologyMasters
$234K - $322K/yr(estimated)

Description

<p><b>About This Role</b></p><p></p><p>The Senior Director, Alzheimer’s Global Diagnostics &amp; Disease Area Strategy, will lead the overall global AD diagnostic pathway strategy and disease area strategy for the Alzheimer’s Disease and Dementia Franchise. Significant collaboration is required across the value chain of subject matter experts and with the regions.</p><p></p><p><b>What You’ll Do</b></p><ul><li>Develop, recommend and direct the implementation of the AD diagnostic pathway commercialization strategies, working collaboratively with global commercialization functions and regional commercialization colleagues.</li><li>Direct the Alzheimer Disease and Dementia Franchise Strategic Annual Process.</li><li>Assess and recommend, in collaboration with cross functional partners, disease area strategies to realize the Biogen ADD Pipeline Strategy.</li><li>Orchestrate strong, collegiate and effective communications across a range of stakeholders including internal cross-functional and regional teams and external vendors, partners, or collaborators as it pertains to commercialization strategies and goals.</li><li>Direct the management of Vendor SOWs and budgets related to approved commercialization strategies, goals, and fiscal year budgets.</li><li>Evaluate competitive intelligence, landscape and market development related to the AD diagnostic pathway commercialization strategies to inform strategy evolution and revised recommendations to drive market growth and simplify the AD diagnostics patient care pathway.</li><li>Direct complex projects and programs associated with the role ensuring deliverables are on time and in line with contracted terms and business deadlines.</li></ul><p></p><p><b>Who You Are</b></p><p>You are a highly collaborative leader who has experience engaging with external experts to integrate perspectives into disease area strategy. You have track record for strong cross functional commercialization leadership in global and market settings, turning strategy into action, analyzing complex information and breaking it down into simple workstreams and high value actions, and effectively leading cross functional teams through problem solving and creating clear recommendations to senior level governance.</p><p></p><p><b>Required Skills</b></p><ul><li>Master’s degree is required</li><li>12&#43; years relevant experience in simplifying patient care pathways, disease areas strategy, pipeline strategy, pharmaceutical and/or biotechnology industry.</li><li>Previous industry experience at the global and local level leading cross functional teams is required.</li><li>Demonstrated history of directing strategies with on time and approved recommendations related to diagnostics pathway and therapeutic programs is a requirement.</li><li>Ability to manage multiple programs simultaneously with cross-functional teams and with external partners.</li><li>Working knowledge of Alzheimer’s Disease diagnostics development, AD Patient care pathway and commercialization process.</li><li>Proven track record of working on collaborative initiatives with alliance partners.</li><li>Ability to apply good judgment within the team</li><li>Excellent verbal, written and interpersonal communication skills</li></ul><p></p><p><b>Preferred</b> <b>Skills</b></p><ul><li>Advanced Doctoral degree preferred</li><li>Alzheimer’s development, launch and/or commercialization experience is preferred.</li><li>Experience in HIV, Oncology, Rare Disease or Cardiometabolic development, launch and/or commercialization may also be relevant.</li></ul><p style="text-align:inherit"><br /> </p>Job Level: Management<p style="text-align:left"><br /><b>Additional Information</b></p><p style="text-align:inherit"></p>The base compensation range for this role is: $234,000.00-$322,000.00<div><p style="text-align:left"><br /><span>Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills &amp; experience, job location, and internal equity.</span></p><p style="text-align:inherit"></p><p style="text-align:left"><span>Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance. </span></p><p style="text-align:inherit"></p><p style="text-align:left"><span>In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families <i>physical, financial, emotional,</i> and <i>social well-being</i>; including, but not limited to:</span></p><ul><li><span>Medical, Dental, Vision, &amp; Life insurances</span></li><li><span>Fitness &amp; Wellness programs including a fitness reimbursement </span></li><li><span>Short- and Long-Term Disability insurance</span></li><li><span>A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)</span></li><li><span>Up to 12 company paid holidays &#43; 3 paid days off for Personal Significance </span></li><li><span>80 hours of sick time per calendar year</span></li><li><span>Paid Maternity and Parental Leave benefit </span></li><li><span>401(k) program participation with company matched contributions</span></li><li><span>Employee stock purchase plan </span></li><li><span>Tuition reimbursement of up to $10,000 per calendar year </span></li><li><span><span>Employee Resource Groups participation</span></span></li></ul><p style="text-align:inherit"></p></div><div><p style="text-align:left"><b>Why Biogen?</b></p><p style="text-align:left">We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.</p><p style="text-align:inherit"></p><p style="text-align:left">At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired.<span> </span><a href="https://nam12.safelinks.protection.outlook.com/?url&#61;https%3A%2F%2Fwww.biogen.com%2Fresponsibility%2Fdiversity-inclusion.html&amp;data&#61;05%7C01%7Cdennis.mercier%40biogen.com%7C67adaf5a6edd4324716208db0dcd2182%7C7b7466bbfe1d47a0b9438ded565c8e54%7C0%7C0%7C638118946897044815%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata&#61;p2vFGx6ZWK7lyBEL4wuNIQJcKSVRZD90VuJxcOkjX04%3D&amp;reserved&#61;0" target="_blank">Read on</a><span> </span>to learn more about our DE&amp;I efforts.</p><p style="text-align:inherit"></p><p style="text-align:left">All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.</p></div>
Biogen

Biogen

BIOTECHNOLOGY

Small Molecules, Biologics, Biosimilars, ASO

LocationCAMBRIDGE, MA
Employees7,500
Open Jobs274
NeuroscienceRare DiseasesImmunology
View Company Profile

Pipeline

Psychometric Validation of Cognitive EndpointsN/A
TysabriN/A
Evaluation of Brain Atrophy in CIS Patients on AvonexN/A
natalizumabN/A
Multicenter Observational Study of Myotonic Dystrophy Type 1N/A